The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Noticeable differences also exist between sexes, with women experiencing more frequent and severe hepatotoxicity.44,45”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [45]
In the citing paper
“Similarly, men appear to be overrepresented with azathioprine, anabolic steroid, and amoxicillin‐clavulanate hepatotoxicity.45–47”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [45]
In the citing paper
“In addition, older subjects appear to be at increased risk of isoniazid and amoxicillin‐clavulanate hepatotoxicity, whereas younger individuals are more prone to develop DILI from anticonvulsants and minocycline.45,46”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [45]
In the citing paper
“Finally, case series demonstrate an overrepresentation of women with diclofenac, macrolide, flucloxacillin, halothane, ibuprofen, interferon beta‐1a, and nitrofurantoin hepatotoxicity.”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406
Self-citationAleo, M. D., Luo, Y., Swiss, R., Bonin, P. D., Potter, D. M., & Will, Y. (2014) · Hepatology · doi:10.1002/hep.27206 · Cited by 215
Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children
Rivkees, S. A., & Szarfman, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2546 · Cited by 177
Research works printed but not linked: 32
- Anderson, 2005, Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics, J Womens Health (Larchmt), 14, 19, 10.1089/jwh.2005.14.19 · DOI · Paper page
- Andrade, 2005, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- Boelsterli, 2007, Mitochondrial abnormalities–a link to idiosyncratic drug hepatotoxicity?, Toxicol. Appl. Pharmacol., 220, 92, 10.1016/j.taap.2006.12.013 · DOI · Paper page
- Chen, 2013, High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury, Hepatology, 58, 388, 10.1002/hep.26208 · DOI · Paper page
- Chen, 2015, Drug-Induced liver injury: interactions between drug properties and host factors, J. Hepatol., 63, 503, 10.1016/j.jhep.2015.04.016 · DOI · Paper page
- Chen, 2013, The liver toxicity knowledge base: a systems approach to a complex end point, Clin. Pharmacol. Ther., 93, 409, 10.1038/clpt.2013.16 · DOI
- Cho, 2013, Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6, PLoS One, 8, 10.1371/journal.pone.0061186 · DOI
- de Lima Toccafondo Vieira, 2014, Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools, Expet Opin. Drug Metabol. Toxicol., 10, 581, 10.1517/17425255.2014.884069 · DOI
- De Valle, 2006, Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic, Aliment. Pharmacol. Ther., 24, 1187, 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
- deLemos, 2016, Amoxicillin-clavulanate-induced liver injury, Dig. Dis. Sci., 61, 2406, 10.1007/s10620-016-4121-6 · DOI
- DuMouchel, 1999, Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System (with discussion), Am. Statistician, 53, 177, 10.1080/00031305.1999.10474456 · DOI · Paper page
- Fontana, 2013, Presentation and outcomes with clinically apparent interferon beta hepatotoxicity, Dig. Dis. Sci., 58, 1766, 10.1007/s10620-012-2553-1 · DOI
- Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 10.1053/j.gastro.2014.03.045 · DOI · Paper page
- Hunt, 1992, Effect of age and gender on the activity of human hepatic CYP3A, Biochem. Pharmacol., 44, 275, 10.1016/0006-2952(92)90010-G · DOI · Paper page
- Hunt, 2014, Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database, Regul. Toxicol. Pharmacol., 70, 519, 10.1016/j.yrtph.2014.09.007 · DOI
- Knowles, 2000, Idiosyncratic drug reactions: the reactive metabolite syndromes, Lancet, 356, 1587, 10.1016/S0140-6736(00)03137-8 · DOI · Paper page
- Lammert, 2010, Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events, Hepatology, 51, 615, 10.1002/hep.23317 · DOI · Paper page
- Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
- Lucena, 2009, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex, Hepatology, 49, 2001, 10.1002/hep.22895 · DOI · Paper page
- Medina-Caliz, 2016, Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury, J. Hepatol., 65, 532, 10.1016/j.jhep.2016.05.003 · DOI · Paper page
- Nichols, 2006, From menarche to menopause: trends among US Women born from 1912 to 1969, Am. J. Epidemiol., 164, 1003, 10.1093/aje/kwj282 · DOI · Paper page
- Pauli-Magnus, 2006, Hepatobiliary transporters and drug-induced cholestasis, Hepatology, 44, 778, 10.1002/hep.21359 · DOI · Paper page
- Russmann, 2010, Pharmacogenetics of drug-induced liver injury, Hepatology, 52, 748, 10.1002/hep.23720 · DOI
- Russo, 2004, Liver transplantation for acute liver failure from drug induced liver injury in the United States, Liver Transplant., 10, 1018, 10.1002/lt.20204 · DOI · Paper page
- Schwartz, 2007, The current state of knowledge on age, sex, and their interactions on clinical pharmacology, Clin. Pharmacol. Ther., 82, 87, 10.1038/sj.clpt.6100226 · DOI · Paper page
- Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
- Shin, 2013, Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data, Pharmacoepidemiol. Drug Saf., 22, 190, 10.1002/pds.3388 · DOI · Paper page
- Suzuki, 2010, Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work, Drug Saf., 33, 503, 10.2165/11535340-000000000-00000 · DOI · Paper page
- Suzuki, 2017, Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury, Liver Int., 37, 1723, 10.1111/liv.13380 · DOI
- Suzuki, 2015, Comedications alter drug-induced liver injury reporting frequency: data mining in the WHO VigiBase, Regul. Toxicol. Pharmacol., 72, 481, 10.1016/j.yrtph.2015.05.004 · DOI · Paper page
- Urban, 2017, Minocycline hepatotoxicity: clinical characterization and identification of HLA-B *35:02 as a risk factor, J. Hepatol., 67, 137, 10.1016/j.jhep.2017.03.010 · DOI · Paper page
- Wynne, 2005, Drug metabolism and ageing, J. Br. Menopause Soc., 11, 51, 10.1258/136218005775544589 · DOI
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationEstrogenic control of mitochondrial function
Klinge, C. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101435 · Cited by 293
Drug induced liver injury: an update
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02885-1 · Cited by 286
Drug-induced liver injury in older people
Lucena, M. I., Sanabria, J., García-Cortes, M., Stephens, C., & Andrade, R. J. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30006-6 · Cited by 77
Metadata
- Authors
- George, N., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A.
- ORCID
- Hunt, Christine M.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 94
- Pages
- 101-107
- ISSN
- 0273-2300
- Cited by
- 46
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. https://app.cochat.ai/papers/10.1016/j.yrtph.2018.01.018
- The paper
- George, N., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A. (2018). Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2018.01.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.